Vir Biotechnology, Inc. (VIR) DCF Valuation

Vir Biotechnology, Inc. (VIR) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Vir Biotechnology, Inc. (VIR) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Looking to assess the intrinsic value of Vir Biotechnology, Inc.? Our (VIR) DCF Calculator integrates real-world data with comprehensive customization options, enabling you to refine your forecasts and make more informed investment choices.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .7 67.2 1,087.1 1,580.5 86.2 176.9 363.0 745.1 1,529.2 3,138.4
Revenue Growth, % 0 9357.81 1516.58 45.39 -94.55 105.24 105.24 105.24 105.24 105.24
EBITDA -173.5 -289.8 420.8 833.1 -664.9 -73.8 -151.4 -310.8 -637.9 -1,309.3
EBITDA, % -24396.91 -430.96 38.71 52.71 -771.47 -41.72 -41.72 -41.72 -41.72 -41.72
Depreciation 4.5 8.8 12.0 15.5 19.5 48.7 100.0 205.3 421.3 864.7
Depreciation, % 635.3 13.11 1.1 0.98021 22.57 27.55 27.55 27.55 27.55 27.55
EBIT -178.0 -298.6 408.8 817.6 -684.3 -74.5 -153.0 -313.9 -644.3 -1,322.3
EBIT, % -25032.21 -444.06 37.6 51.73 -794.04 -42.13 -42.13 -42.13 -42.13 -42.13
Total Cash 383.4 736.9 708.1 2,402.0 1,522.4 164.5 337.7 693.1 1,422.6 2,919.6
Total Cash, percent .1 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 773.1 .0 .0
Account Receivables, % 0 0 71.12 0 0
Inventories .0 .0 8.6 .0 .0 .3 .6 1.2 2.4 5.0
Inventories, % 0 0 0.79057 0 0 0.15811 0.15811 0.15811 0.15811 0.15811
Accounts Payable 5.9 5.1 6.5 6.4 6.3 41.0 84.2 172.7 354.5 727.5
Accounts Payable, % 827.14 7.55 0.59987 0.40633 7.35 23.18 23.18 23.18 23.18 23.18
Capital Expenditure -8.9 -6.5 -21.8 -68.0 -21.6 -49.9 -102.4 -210.2 -431.5 -885.6
Capital Expenditure, % -1257.38 -9.74 -2.01 -4.3 -25.03 -28.22 -28.22 -28.22 -28.22 -28.22
Tax Rate, % 2.09 2.09 2.09 2.09 2.09 2.09 2.09 2.09 2.09 2.09
EBITAT -178.1 -298.7 393.0 559.1 -670.0 -68.9 -141.5 -290.3 -595.9 -1,223.0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -176.7 -297.2 -397.1 1,288.2 -672.2 -60.9 -127.5 -261.7 -537.1 -1,102.2
WACC, % 6.37 6.37 6.35 6.21 6.36 6.33 6.33 6.33 6.33 6.33
PV UFCF
SUM PV UFCF -1,618.7
Long Term Growth Rate, % 4.00
Free cash flow (T + 1) -1,146
Terminal Value -49,168
Present Terminal Value -36,172
Enterprise Value -37,791
Net Debt -130
Equity Value -37,661
Diluted Shares Outstanding, MM 134
Equity Value Per Share -280.78

What You Will Get

  • Real VIR Financials: Access to historical and projected data for precise valuation.
  • Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
  • Dynamic Calculations: Intrinsic value and NPV are computed in real-time.
  • Scenario Analysis: Evaluate various scenarios to assess Vir Biotechnology’s future outlook.
  • User-Friendly Design: Designed for professionals while remaining approachable for newcomers.

Key Features

  • Comprehensive Data: Vir Biotechnology’s historical financial records and pre-filled projections.
  • Customizable Inputs: Modify discount rates, tax percentages, revenue growth, and profit margins.
  • Real-Time Insights: Observe Vir Biotechnology’s intrinsic value update instantly.
  • Intuitive Visual Outputs: Dashboard graphs showcase valuation outcomes and essential metrics.
  • Designed for Precision: A professional-grade tool for analysts, investors, and finance professionals.

How It Works

  1. Download the Template: Gain immediate access to the Excel-based VIR DCF Calculator.
  2. Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and additional parameters.
  3. Instant Calculations: The model automatically recalculates Vir Biotechnology’s intrinsic value.
  4. Test Scenarios: Experiment with various assumptions to assess potential changes in valuation.
  5. Analyze and Decide: Utilize the findings to inform your investment or financial analysis.

Why Choose This Calculator for Vir Biotechnology, Inc. (VIR)?

  • Designed for Experts: A sophisticated tool tailored for analysts, investors, and industry specialists.
  • Accurate Data: Vir Biotechnology’s historical and projected financials are preloaded for precision.
  • Flexible Scenario Analysis: Effortlessly test various forecasts and assumptions.
  • Insightful Outputs: Automatically computes intrinsic value, NPV, and essential metrics.
  • User-Friendly: Comprehensive instructions lead you through each step of the calculation.

Who Should Use This Product?

  • Investors: Evaluate Vir Biotechnology’s valuation prior to making investment decisions.
  • CFOs and Financial Analysts: Enhance efficiency in valuation procedures and assess financial forecasts.
  • Startup Founders: Understand the valuation methods applied to prominent biotech firms like Vir Biotechnology.
  • Consultants: Create detailed valuation reports for your clients in the biotech sector.
  • Students and Educators: Utilize real-world data from Vir Biotechnology to learn and teach valuation methodologies.

What the Template Contains

  • Pre-Filled Data: Contains Vir Biotechnology's historical financials and projections.
  • Discounted Cash Flow Model: Editable DCF valuation model featuring automatic calculations.
  • Weighted Average Cost of Capital (WACC): A dedicated sheet for WACC calculation based on user-defined inputs.
  • Key Financial Ratios: Assess Vir Biotechnology's profitability, efficiency, and leverage metrics.
  • Customizable Inputs: Easily modify revenue growth, margins, and tax rates.
  • Clear Dashboard: Visual representations and tables summarizing essential valuation outcomes.

No products were found matching.